The Claim
In male C57BL/6 mice, a diet containing 34% fructose increases hepatic expression of SREBP-1c and PPAR-γ and decreases hepatic expression of PPAR-α, resulting in a shift from fatty acid oxidation to lipogenesis and contributing to the development of nonalcoholic fatty liver disease.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In male C57BL/6 mice, a diet with 34% fructose increases the activity of genes that promote fat production in the liver and decreases the activity of genes that break down fat, leading to fat accumulation in the liver.
See the scientific wording
In male C57BL/6 mice, a diet with 34% fructose increases hepatic expression of SREBP-1c and PPAR-γ while decreasing PPAR-α, leading to a shift toward lipogenesis and away from fatty acid oxidation, contributing to nonalcoholic fatty liver disease.
When the liver processes large amounts of fructose, it produces excess fat-building blocks and shuts down fat-burning machinery, causing fat to pile up in liver cells. This happens because fructose turns on genes that make fat and turns off genes that burn fat, leading to fatty liver disease.
What the research says
1 studyStudy: Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity
In mice, eating a lot of fructose makes the liver start making more fat and stop burning fat, even if the mice don’t get heavier—this causes fat to build up in the liver.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.